Colorectal Cancer Trial Now Under Way
Below is a MRR and PLR article in category Health Fitness -> subcategory Disease Illness.
Colorectal Cancer Trial Underway
A crucial study is now in progress to enhance treatment options for colorectal cancer patients.
Overview
This year, over 145,000 Americans will be diagnosed with colorectal cancer, the third most common cancer in the country. This condition involves the formation of malignant cells in the colon or rectum. Despite advancements, the incidence and mortality rates for colorectal cancer have only slightly decreased or stabilized over the past decade. The American Cancer Society predicts that more than 56,000 individuals will die from this disease this year.
The PACCE Trial
In an effort to improve outcomes, a significant clinical trial, known as the PACCE (Panitumumab Advanced Colorectal Cancer Evaluation), is underway across the nation. This Phase 3 trial aims to examine the effects of two targeted cancer therapies combined with chemotherapy for patients with metastatic colorectal cancer.
Participating in the Trial
Institutions nationwide are enrolling patients for the PACCE trial, and there might be a site near you. The study investigates the use of chemotherapy, which destroys cancer cells, along with bevacizumab, a drug that inhibits blood vessel growth to the tumor. Additionally, the trial explores panitumumab, an experimental treatment thought to prevent tumor growth.
Participants receive either chemotherapy and bevacizumab or a combination of panitumumab with chemotherapy and bevacizumab, allowing researchers to evaluate the effectiveness of these treatments.
You can find the original non-AI version of this article here: Colorectal Cancer Trial Now Under Way.
You can browse and read all the articles for free. If you want to use them and get PLR and MRR rights, you need to buy the pack. Learn more about this pack of over 100 000 MRR and PLR articles.